CME GROUP INC. 8-K

What Happened
CME Group Inc. announced pricing changes to its clients and furnished a Regulation FD disclosure on February 2, 2026 via Special Executive Report 9676. A copy of that notice has been posted to the company’s website. The company filed the notice under Item 7.01 (Regulation FD Disclosure) of Form 8-K.

Key Details

• Date of disclosure: February 2, 2026.
• Notice reference: Special Executive Report 9676; posted to CME Group’s website.
• Filing section: Item 7.01 (Regulation FD Disclosure) — the company furnished the notice rather than reporting other financial results.
• Administrative detail: Form 8-K was signed by Lynne Fitzpatrick, Senior Managing Director, President and Chief Financial Officer. The cover page was furnished as Inline XBRL (Exhibit 104) under Item 9.01.

Why It Matters
Pricing changes can affect trading costs for customers and fee-related revenue for CME Group, so investors should review the posted Special Executive Report 9676 for specifics. The 8-K does not disclose the financial impact or detailed terms of the pricing changes; it is a regulatory disclosure notifying clients and the market of the change.